Author： Juan F. Viles-Gonzalez Juan Gaztanaga Urooj M. Zafar Valentin Fuster Juan J. Badimon
Publisher： Adis International
ISSN： 1175-3277
Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.6, 2004-01, pp. : 379-384
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical Pharmacology of Direct and Indirect Factor Xa Inhibitors
By Rupprecht Hans-Juergen Blank Ralf
Drugs, Vol. 70, Iss. 16, 2010-11 ,pp. :
Access to resources
Recommend
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. :
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. :
Recent advances in Factor Xa inhibitors
By Betz Andreas
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 6, 2001-06 ,pp. :